1 INTRODUCTION 27
1.1 STUDY OBJECTIVES 27
1.2 MARKET DEFINITION 27
1.2.1 INCLUSIONS AND EXCLUSIONS 27
1.3 MARKET SCOPE 28
1.3.1 MARKETS COVERED 28
FIGURE 1 CARDIAC SAFETY SERVICES MARKET SEGMENTATION 28
1.3.2 YEARS CONSIDERED 28
1.4 CURRENCY CONSIDERED 29
1.5 LIMITATIONS 29
1.6 STAKEHOLDERS 29
1.6.1 RECESSION IMPACT 30
2 RESEARCH METHODOLOGY 31
2.1 RESEARCH DATA 31
FIGURE 2 RESEARCH DESIGN 31
2.1.1 SECONDARY DATA 32
2.1.2 PRIMARY DATA 33
FIGURE 3 CARDIAC SAFETY SERVICES MARKET: BREAKDOWN OF PRIMARIES 33
2.2 MARKET SIZE ESTIMATION 34
FIGURE 4 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS 34
FIGURE 5 MARKET SIZE ESTIMATION FOR CARDIAC SAFETY SERVICES: REVENUE SHARE ANALYSIS 35
2.2.1 INSIGHTS FROM PRIMARIES 36
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS 36
2.2.2 SEGMENTATION ASSESSMENT (BY TYPE, SERVICE TYPE, AND END USER) 36
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 36
2.3 GROWTH FORECAST 37
FIGURE 8 CARDIAC SAFETY SERVICES MARKET: CAGR PROJECTIONS 38
FIGURE 9 CARDIAC SAFETY SERVICES MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 38
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 39
FIGURE 10 DATA TRIANGULATION METHODOLOGY 39
2.5 RESEARCH ASSUMPTIONS 40
2.6 RISK ANALYSIS 40
2.7 RECESSION IMPACT ANALYSIS 40
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH) 40
 
3 EXECUTIVE SUMMARY 42
FIGURE 11 CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 42
FIGURE 12 CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2023 VS. 2028 (USD MILLION) 43
FIGURE 13 CARDIAC SAFETY SERVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 43
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF CARDIAC SAFETY SERVICES MARKET 44
4 PREMIUM INSIGHTS 45
4.1 CARDIAC SAFETY SERVICES MARKET OVERVIEW 45
FIGURE 15 RISING INCIDENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET GROWTH DURING FORECAST PERIOD 45
4.2 NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET, BY TYPE AND COUNTRY (2022) 46
FIGURE 16 INTEGRATED SERVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022 46
4.3 CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2023 VS. 2028 46
FIGURE 17 ECG/HOLTER MEASUREMENT SERVICES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 46
4.4 CARDIAC SAFETY SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 47
FIGURE 18 EUROPEAN COUNTRIES TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD 47
5 MARKET OVERVIEW 48
5.1 INTRODUCTION 48
5.2 MARKET DYNAMICS 49
FIGURE 19 CARDIAC SAFETY SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, CHALLENGES, AND TRENDS 49
TABLE 2 CARDIAC SAFETY SERVICES MARKET: IMPACT ANALYSIS 50
5.2.1 DRIVERS 50
5.2.1.1 Rising incidence of cardiovascular diseases 50
5.2.1.2 Increasing outsourcing of services to CROs 51
5.2.1.3 High number of clinical trials for cardiac treatments 52
FIGURE 20 TOTAL CLINICAL TRIAL REGISTRATIONS WORLDWIDE (2000−2022) 52
5.2.2 RESTRAINTS 53
5.2.2.1 Stringent regulations and compliance guidelines 53
5.2.2.2 Inadequacy of cardiotoxicity testing 54
5.2.3 OPPORTUNITIES 54
5.2.3.1 Emergence of innovative testing methods 54
5.2.3.2 Growth in biosimilars and biologics development 55
5.2.4 CHALLENGES 56
5.2.4.1 High cost of cardiac safety evaluation services 56
5.2.5 TRENDS 56
5.2.5.1 Rising technological advancements 56
5.2.5.2 Transition to patient-centric approach 57
5.3 TECHNOLOGY ANALYSIS 58
5.4 VALUE CHAIN ANALYSIS 59
FIGURE 21 CARDIAC SAFETY SERVICES MARKET: VALUE CHAIN ANALYSIS 59
5.5 ECOSYSTEM ANALYSIS 60
FIGURE 22 CARDIAC SAFETY SERVICES MARKET: ECOSYSTEM ANALYSIS 60
5.6 PORTER’S FIVE FORCES ANALYSIS 60
TABLE 3 CARDIAC SAFETY SERVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 60
5.6.1 INTENSITY OF COMPETITIVE RIVALRY 60
5.6.2 BARGAINING POWER OF SUPPLIERS 61
5.6.3 BARGAINING POWER OF BUYERS 61
5.6.4 THREAT OF SUBSTITUTES 61
5.6.5 THREAT OF NEW ENTRANTS 61
5.7 REGULATORY ANALYSIS 61
5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 61
TABLE 4 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 61
TABLE 5 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62
TABLE 6 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62
TABLE 7 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63
TABLE 8 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 63
5.8 PRICING ANALYSIS 64
5.9 KEY CONFERENCES AND EVENTS 65
TABLE 9 CARDIAC SAFETY SERVICES MARKET: LIST OF KEY CONFERENCES AND EVENTS (2023–2024) 65
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA 66
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 66
FIGURE 23 CARDIAC SAFETY SERVICES MARKET: INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 66
5.10.2 BUYING CRITERIA 67
FIGURE 24 KEY BUYING CRITERIA FOR END USERS 67
6 CARDIAC SAFETY SERVICES MARKET, BY TYPE 68
6.1 INTRODUCTION 69
TABLE 10 CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 69
6.2 INTEGRATED SERVICES 69
6.2.1 COMPREHENSIVE DATA INTEGRATION AND IMPROVED QUALITY TO PROPEL MARKET 69
TABLE 11 INTEGRATED CARDIAC SAFETY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 70
TABLE 12 NORTH AMERICA: INTEGRATED CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 70
TABLE 13 EUROPE: INTEGRATED CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 71
TABLE 14 ASIA PACIFIC: INTEGRATED CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 71
TABLE 15 LATIN AMERICA: INTEGRATED CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 72
6.3 STANDALONE SERVICES 72
6.3.1 COST-EFFECTIVE BENEFITS TO SUPPORT MARKET GROWTH 72
TABLE 16 STANDALONE CARDIAC SAFETY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 73
TABLE 17 NORTH AMERICA: STANDALONE CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 73
TABLE 18 EUROPE: STANDALONE CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 74
TABLE 19 ASIA PACIFIC: STANDALONE CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 74
TABLE 20 LATIN AMERICA: STANDALONE CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 75
7 CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE 76
7.1 INTRODUCTION 77
TABLE 21 CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 77
7.2 ECG/HOLTER MEASUREMENT SERVICES 77
7.2.1 FEATURES SUCH AS TREND ASSESSMENT AND ENHANCED QUALITY METRICS TO BOOST DEMAND 77
TABLE 22 ECG/HOLTER MEASUREMENT SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 78
TABLE 23 NORTH AMERICA: ECG/HOLTER MEASUREMENT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 78
TABLE 24 EUROPE: ECG/HOLTER MEASUREMENT SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 25 ASIA PACIFIC: ECG/HOLTER MEASUREMENT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 26 LATIN AMERICA: ECG/HOLTER MEASUREMENT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 80
7.3 BLOOD PRESSURE MEASUREMENT SERVICES 80
7.3.1 GROWING IMPORTANCE IN CARDIOVASCULAR HEALTH ASSESSMENT TO SUPPORT GROWTH 80
TABLE 27 BLOOD PRESSURE MEASUREMENT SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 81
TABLE 28 NORTH AMERICA: BLOOD PRESSURE MANAGEMENT SERVICES MARKET BY COUNTRY, 2021–2028 (USD MILLION) 81
TABLE 29 EUROPE: BLOOD PRESSURE MANAGEMENT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 30 ASIA PACIFIC: BLOOD PRESSURE MANAGEMENT SERVICES, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 31 LATIN AMERICA: BLOOD PRESSURE MANAGEMENT SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 83
7.4 CARDIOVASCULAR IMAGING SERVICES 83
7.4.1 NEED TO ASSESS DRUG EFFICACY AND SAFETY TO PROPEL DEMAND 83
TABLE 32 CARDIOVASCULAR IMAGING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 84
TABLE 33 NORTH AMERICA: CARDIOVASCULAR IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 34 EUROPE: CARDIOVASCULAR IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 85
TABLE 35 ASIA PACIFIC: CARDIOVASCULAR IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 85
TABLE 36 LATIN AMERICA: CARDIOVASCULAR IMAGING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
7.5 THOROUGH QT STUDIES 86
7.5.1 NEED TO CONDUCT CLINICAL INVESTIGATIONS AND MEASURE MEDICAL INTERVENTION TO DRIVE GROWTH 86
TABLE 37 THOROUGH QT STUDIES MARKET, BY REGION, 2021–2028 (USD MILLION) 87
TABLE 38 NORTH AMERICA: THOROUGH QT STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 39 EUROPE: THOROUGH QT STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 40 ASIA PACIFIC: THOROUGH QT STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 41 LATIN AMERICA: THOROUGH QT STUDIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
7.6 OTHER CARDIAC SAFETY SERVICES 89
TABLE 42 OTHER CARDIAC SAFETY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 89
TABLE 43 NORTH AMERICA: OTHER CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 44 EUROPE: OTHER CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90
TABLE 45 ASIA PACIFIC: OTHER CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 46 LATIN AMERICA: OTHER CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
8 CARDIAC SAFETY SERVICES MARKET, BY END USER 92
8.1 INTRODUCTION 93
TABLE 47 CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 93
8.2 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES 93
8.2.1 GROWING COLLABORATIONS FOR CLINICAL TRIALS TO PROPEL MARKET 93
TABLE 48 CARDIAC SAFETY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2021–2028 (USD MILLION) 94
TABLE 49 NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 94
TABLE 50 EUROPE: CARDIAC SAFETY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 51 ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 52 LATIN AMERICA: CARDIAC SAFETY SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 96
8.3 CONTRACT RESEARCH ORGANIZATIONS (CROS) 96
8.3.1 RISING OUTSOURCING OF DRUG DISCOVERY SERVICES TO DRIVE MARKET 96
TABLE 53 CARDIAC SAFETY SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2021–2028 (USD MILLION) 96
TABLE 54 NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 55 EUROPE: CARDIAC SAFETY SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 56 ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2021–2028 (USD MILLION) 98
TABLE 57 LATIN AMERICA: CARDIAC SAFETY SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY COUNTRY, 2021–2028 (USD MILLION) 98
9 CARDIAC SAFETY SERVICES MARKET, BY REGION 99
9.1 INTRODUCTION 100
TABLE 58 CARDIAC SAFETY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 100
9.2 NORTH AMERICA 100
FIGURE 25 NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET SNAPSHOT 101
TABLE 59 NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 60 NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 102
TABLE 61 NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 103
TABLE 62 NORTH AMERICA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 103
9.2.1 US 104
9.2.1.1 Increasing clinical trials for drug discovery & development to drive market 104
TABLE 63 TOTAL NUMBER OF CLINICAL TRIALS REGISTERED 104
TABLE 64 US: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 105
TABLE 65 US: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 105
TABLE 66 US: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 105
9.2.2 CANADA 106
9.2.2.1 Availability of high-end facilities for drug discovery to propel market 106
TABLE 67 CANADA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 106
TABLE 68 CANADA: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 107
TABLE 69 CANADA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 107
9.2.3 NORTH AMERICA: RECESSION IMPACT 108
9.3 EUROPE 108
FIGURE 26 EUROPE: CARDIAC SAFETY SERVICES MARKET SNAPSHOT 109
TABLE 70 EUROPE: CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
TABLE 71 EUROPE: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 110
TABLE 72 EUROPE: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 111
TABLE 73 EUROPE: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 111
9.3.1 GERMANY 111
9.3.1.1 High pharmaceutical production to propel market 111
TABLE 74 GERMANY: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 112
TABLE 75 GERMANY: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 112
TABLE 76 GERMANY: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 113
9.3.2 UK 113
9.3.2.1 Growth in life science research to drive market 113
TABLE 77 UK: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 113
TABLE 78 UK: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 114
TABLE 79 UK: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 114
9.3.3 FRANCE 114
9.3.3.1 Growing focus on biosimilars to fuel market 114
TABLE 80 FRANCE: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 115
TABLE 81 FRANCE: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 115
TABLE 82 FRANCE: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 116
9.3.4 ITALY 116
9.3.4.1 Availability of funding for novel services to support market growth 116
TABLE 83 ITALY: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 116
TABLE 84 ITALY: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 117
TABLE 85 ITALY: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 117
9.3.5 SPAIN 117
9.3.5.1 Presence of multinational pharma companies to drive market 117
TABLE 86 SPAIN: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 118
TABLE 87 SPAIN: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 118
TABLE 88 SPAIN: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 119
9.3.6 REST OF EUROPE 119
TABLE 89 REST OF EUROPE: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 120
TABLE 90 REST OF EUROPE: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 120
TABLE 91 REST OF EUROPE: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 121
9.3.7 EUROPE: RECESSION IMPACT 121
9.4 ASIA PACIFIC 121
TABLE 92 ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 93 ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 122
TABLE 94 ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 123
TABLE 95 ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 123
9.4.1 CHINA 123
9.4.1.1 China to dominate APAC market for cardiac safety services 123
TABLE 96 CHINA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 124
TABLE 97 CHINA: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 124
TABLE 98 CHINA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 125
9.4.2 JAPAN 125
9.4.2.1 Supportive regulatory policies for safety measures to drive market 125
TABLE 99 JAPAN: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 100 JAPAN: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 126
TABLE 101 JAPAN: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 126
9.4.3 INDIA 126
9.4.3.1 Rising growth in pharmaceutical & biotechnology industries to propel market 126
TABLE 102 INDIA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 127
TABLE 103 INDIA: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 127
TABLE 104 INDIA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 128
9.4.4 AUSTRALIA 128
9.4.4.1 Rising investments by medical device companies to support market growth 128
TABLE 105 AUSTRALIA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 128
TABLE 106 AUSTRALIA: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 129
TABLE 107 AUSTRALIA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 129
9.4.5 REST OF ASIA PACIFIC 129
TABLE 108 REST OF ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 130
TABLE 109 REST OF ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 130
TABLE 110 REST OF ASIA PACIFIC: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 131
9.4.6 ASIA PACIFIC: RECESSION IMPACT 131
9.5 LATIN AMERICA 131
TABLE 111 LATIN AMERICA: CARDIAC SAFETY SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 112 LATIN AMERICA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 132
TABLE 113 LATIN AMERICA: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 132
TABLE 114 LATIN AMERICA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 133
9.5.1 BRAZIL 133
9.5.1.1 Low costs and presence of skilled clinical investigators to drive market 133
TABLE 115 BRAZIL: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 133
TABLE 116 BRAZIL: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 134
TABLE 117 BRAZIL: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 134
9.5.2 REST OF LATIN AMERICA 134
TABLE 118 REST OF LATIN AMERICA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 135
TABLE 119 REST OF LATIN AMERICA: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 135
TABLE 120 REST OF LATIN AMERICA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 136
9.5.3 LATIN AMERICA: RECESSION IMPACT 136
9.6 MIDDLE EAST 136
9.6.1 GROWING CRO HUB TO DRIVE MARKET 136
TABLE 121 MIDDLE EAST: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 122 MIDDLE EAST: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 137
TABLE 123 MIDDLE EAST: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 138
9.6.2 MIDDLE EAST: RECESSION IMPACT 138
9.7 AFRICA 139
9.7.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES TO SUPPORT MARKET GROWTH 139
TABLE 124 AFRICA: CARDIAC SAFETY SERVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 139
TABLE 125 AFRICA: CARDIAC SAFETY SERVICES MARKET, BY SERVICE TYPE, 2021–2028 (USD MILLION) 140
TABLE 126 AFRICA: CARDIAC SAFETY SERVICES MARKET, BY END USER, 2021–2028 (USD MILLION) 140
9.7.2 AFRICA: RECESSION IMPACT 141
10 COMPETITIVE LANDSCAPE 142
10.1 INTRODUCTION 142
10.2 STRATEGIES ADOPTED BY KEY PLAYERS 143
FIGURE 27 CARDIAC SAFETY SERVICES MARKET: STRATEGIES ADOPTED BY KEY PLAYERS (2020−2023) 143
10.3 MARKET SHARE ANALYSIS 144
FIGURE 28 CARDIAC SAFETY SERVICES MARKET: MARKET SHARE ANALYSIS OF KEY PLAYERS (2022) 144
TABLE 127 CARDIAC SAFETY SERVICES MARKET: INTENSITY OF COMPETITIVE RIVALRY 144
10.4 REVENUE SHARE ANALYSIS 145
FIGURE 29 REVENUE SHARE ANALYSIS FOR KEY COMPANIES (2020−2022) 145
10.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS 146
10.5.1 STARS 146
10.5.2 PERVASIVE PLAYERS 146
10.5.3 EMERGING LEADERS 146
10.5.4 PARTICIPANTS 147
FIGURE 30 CARDIAC SAFETY SERVICES MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022) 147
 
10.6 COMPETITIVE BENCHMARKING OF LEADING 25 PLAYERS (2022) 148
10.6.1 SERVICE FOOTPRINT OF COMPANIES (25 COMPANIES) 148
TABLE 128 CARDIAC SAFETY SERVICES MARKET: SERVICE FOOTPRINT ANALYSIS OF KEY PLAYERS 148
10.6.2 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES) 149
TABLE 129 CARDIAC SAFETY SERVICES MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS 149
10.7 COMPANY EVALUATION MATRIX FOR STARTUPS/SMES 150
10.7.1 PROGRESSIVE COMPANIES 150
10.7.2 RESPONSIVE COMPANIES 150
10.7.3 DYNAMIC COMPANIES 150
10.7.4 STARTING BLOCKS 150
FIGURE 31 CARDIAC SAFETY SERVICES MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022) 151
10.8 COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS (2022) 152
TABLE 130 CARDIAC SAFETY SERVICES MARKET: DETAILED LIST OF STARTUPS/SME PLAYERS 152
TABLE 131 CARDIAC SAFETY SERVICES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SME PLAYERS 153
10.9 COMPETITIVE SCENARIO AND TRENDS 153
10.9.1 SERVICE LAUNCHES 153
TABLE 132 CARDIAC SAFETY SERVICES MARKET: SERVICE LAUNCHES (JANUARY 2020−SEPTEMBER 2023) 153
10.9.2 DEALS 154
TABLE 133 CARDIAC SAFETY SERVICES MARKET: DEALS (JANUARY 2020−SEPTEMBER 2023) 154
10.9.3 OTHER DEVELOPMENTS 155
TABLE 134 CARDIAC SAFETY SERVICES MARKET: OTHER DEVELOPMENTS (JANUARY 2020−SEPTEMBER 2023) 155
11 COMPANY PROFILES 157
11.1 KEY PLAYERS 157
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
11.1.1 LABORATORY CORPORATION OF AMERICA HOLDINGS 157
TABLE 135 LABORATORY CORPORATION OF AMERICA HOLDINGS: BUSINESS OVERVIEW 157
FIGURE 32 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2022) 158
11.1.2 MEDPACE 160
TABLE 136 MEDPACE: BUSINESS OVERVIEW 160
FIGURE 33 MEDPACE: COMPANY SNAPSHOT (2022) 160
11.1.3 KONINKLIJKE PHILIPS N.V. 163
TABLE 137 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 163
FIGURE 34 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022) 164
11.1.4 CLARIO 166
TABLE 138 CLARIO: BUSINESS OVERVIEW 166
11.1.5 NCARDIA 168
TABLE 139 NCARDIA: BUSINESS OVERVIEW 168
11.1.6 IQVIA 169
TABLE 140 IQVIA: BUSINESS OVERVIEW 169
FIGURE 35 IQVIA: COMPANY SNAPSHOT (2022) 170
11.1.7 CERTARA 171
TABLE 141 CERTARA: BUSINESS OVERVIEW 171
FIGURE 36 CERTARA: COMPANY SNAPSHOT (2022) 172
11.1.8 PPD, INC. (PART OF THERMO FISHER SCIENTIFIC, INC.) 173
TABLE 142 PPD, INC.: BUSINESS OVERVIEW 173
FIGURE 37 PPD, INC.: COMPANY SNAPSHOT (2022) 174
11.1.9 SGS S.A. 177
TABLE 143 SGS S.A.: BUSINESS OVERVIEW 177
FIGURE 38 SGS S.A.: COMPANY SNAPSHOT (2022) 178
11.1.10 ICON PLC 180
TABLE 144 ICON PLC: BUSINESS OVERVIEW 180
FIGURE 39 ICON PLC: COMPANY SNAPSHOT (2022) 180
11.1.11 WUXI APPTEC 182
TABLE 145 WUXI APPTEC: BUSINESS OVERVIEW 182
FIGURE 40 WUXI APPTEC: COMPANY SNAPSHOT (2022) 183
11.1.12 CHARLES RIVER LABORATORIES 184
TABLE 146 CHARLES RIVER LABORATORIES: BUSINESS OVERVIEW 184
FIGURE 41 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT 185
11.1.13 EUROFINS SCIENTIFIC 186
TABLE 147 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW 186
FIGURE 42 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT 186
11.1.14 FRONTAGE LABS 188
TABLE 148 FRONTAGE LABS: BUSINESS OVERVIEW 188
FIGURE 43 FRONTAGE LABS: COMPANY SNAPSHOT (2022) 189
11.1.15 BANOOK GROUP 191
TABLE 149 BANOOK GROUP: BUSINESS OVERVIEW 191
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS 193
11.2.1 BIOTRIAL 193
11.2.2 CELERION 193
11.2.3 RICHMOND PHARMACOLOGY 194
11.2.4 PHYSIOSTIM 194
11.2.5 SHANGHAI MEDICILON INC. 195
11.2.6 ACM GLOBAL LABORATORIES 195
11.2.7 WORLDWIDE CLINICAL TRIALS 196
11.2.8 NOVA RESEARCH LABORATORIES LLC 196
11.2.9 BIOBEAT 197
11.2.10 CRS. EXPERTS. EARLY PHASE. 197
12 APPENDIX 198
12.1 DISCUSSION GUIDE 198
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 202
12.3 CUSTOMIZATION OPTIONS 204
12.4 RELATED REPORTS 204
12.5 AUTHOR DETAILS 205